Investigations into the effect of clomiphene citrate stimulation on endometrial differentiation were retrospectively performed in the mid-luteal phase on 21 patients undergoing ovulation induction prior to artificial insemination. A high incidence of irregular endometrial development was seen using morphological and morphometric criteria,* in addition, increasing stromal oedema after clomiphene citrate treatment was observed. Measurable differences in glandular development (Le. numbers of glands and glandular epithelial height) were found in early luteal phase biopsies (LH+2/+6) from patients treated with clomiphene citrate and normal fertile controls. Impaired endometrial development in the early luteal phase, which is a sensitive interval hi preparation for Implantation, might lead to an effective asynchrony between embryonic and uterine development and unfavourably influence the outcome of implantation.
Introduction
The assessment of endometrial function under physiological conditions is one of the most controversial areas in reproduction, and the situation is further complicated during human assisted procreation. Different strategies have been adopted for inducing follicular growth and, while all systems of ovarian stimulation may improve the hormonal status of the patient, they do not necessarily lead to a receptive endometrium suitable for implantation (Sterzik et al, 1988; Rogers et al., 1991; Bonhoff et al, 1993) . One of the major drugs used for infertility treatment is clomiphene citrate (a non-steroidal synthetic compound with both oestrogenic and anti-oestrogenic activity) which in 1967 was approved for human use by the US Food and Drug Administration. By 1991 it had been prescribed 731 000 times in the USA (Wysowski, 1993) .
Previous studies have revealed conflicting data as to the effect of clomiphene citrate on pregnancy rates, with a range of rates from 4 to 25% having been considered as normal in assisted procreation (Saunders et al, 1992; Balasch et al, 844 1994; Agarwal and Buyalos, 1995) . The effects of clomiphene citrate on the reproductive tract have been a matter of concern for many years (Clark and Markaverich, 1982; Blankstein, 1991) . Several studies have reported adverse effects of clomiphene citrate on oestrogen-dependent tissues such as the ovary, cervix and endometrium (Yeko et al, 1992; Gelety and Buyalos, 1993; Rodin et al, 1994) . Thus, clomiphene citrate may have divergent activities, and the effect of clomiphene citrate at a cellular level may vary from one oestrogendependent tissue to another. In the postovulatory endometrium, treatment with clomiphene citrate has led to conflicting results. For instance, some authors could not find any effects in fertile women (Thatcher etal, 1988; Fritz etal, 1991; Ii etal, 1992) whereas others postulated impaired endometrial development (Fazlebas et al, 1991; Yeko et al., 1992) . In infertile women the underlying pathophysiology seems to lead, after clomiphene citrate treatment, in most cases to an inadequate endometrial development (Sterzik et al, 1988; Bonhoff et al, 1993; Massai et al, 1993) . The aims of the present study were therefore to evaluate, in an objective quantitative way, endometrial changes following clomiphene citrate treatment. The morphometric results following treatment are compared with findings in normal fertile women.
Materials and methods

Study group
The patient group consisted of women (n = 21) undergoing ovarian stimulation in preparation for artificial insemination. These women had regular menstrual cycles of 25-35 days duration. The average age of the women in the study was 33.2 years (range 26-39) and did not differ from that of the group of fertile women chosen as controls. Clomiphene citrate was used in dosages of 50-150 mg/day on cycle days 3-7.
During the treatment, patients were checked by regular ultrasonography from day 7 of the cycle to the day of ovulation. Blood samples were drawn for the assessment of luteinizing hormone (LH), 17pV-oestradiol and progesterone concentrations. The radioimmunoassays used have been described previously (Bonhoff et at, 1990) . In four patients, ovulation was induced with human chorionic gonadotrophin (HCG, 5000 IU, Predalon; Organon, Oberschleipheim, Germany) on the 12th, 13th, or 14th day of the cycle and ovulation was expected to occur 36 h later. In all other cases, spontaneous ovulation was observed. To determine timing of ovulation (LH±0) several criteria were used, including measurement of LH in serum, ultrasonic appraisal of the follicle(s) and cervical mucus assessment Fertile group A total of 22 controls (age range 20-40 years) were selected from a group of 95 apparently healthy women with a history of regular 5.8 ± 9.4
•Data for fertile women were taken from Johannisson et aL (1987) .
menstrual cycles and normal pregnancies, and a hormonal profile compatible with normal luteal function (for details, see Johannisson et al., 1987) . Midcycle LH surge was used as point of reference, and endometrial biopsies were obtained between day LH+2 and LH+6 in 13 women and between day LH+7 and LH+10 in nine women.
Evaluations of the biopsies were carried out as described below and were identical in the study group and controls.
Morphological and morphometric analysis
Endometrial biopsies were performed as an outpatient procedure on days 2-11 after HCG application, and/or the spontaneous LH surge, using a Nowak curette. After fixation in buffered formalin, the tissue was embedded in paraffin, sectioned and stained with haematoxylin/ eosin for microscopic evaluation (Bonhoff et al., 1990) . First assessment of the sections was performed for diagnostic purposes, then an evaluation followed, using the histological criteria of Noyes et al. (1950) combined with a more objective quantitative histological technique.
Of each sample, only the functional endometrial layer was subjected to a semiquantitative morphometric analysis. An evaluation using an image analysis system (TMTEC7EXCELL; IMTEC AR, Uppsala, Sweden) as described previously (Johannisson et aL, 1982; Bonhoff et aL, 1993) was carried out in a limited number of cases, the majority of whom belonged to the group of patients who had received &100 mg/day clomiphene citrate. The semiquantitative analysis was performed by two independent observers (A.B. and EJ.) on coded slides. Morphometric parameters shown to be specifically sensitive to tissue differentiation were chosen and included the following indices (Johannisson et aL, 1982) : (i) number of glands per mm 2 , (ii) diameter of glands (urn), (iii) glandular epithelial height (urn), (iv) number of vacuolated cells per 1000 glandular cells. Five indices were included in the semiquantitative analysis and, using a scoring system (1 = weak to 5 = strong), the following parameters were estimated: pseudostratification in the glandular epithelium, stromal oedema, predecidual reaction of the stroma, glandular secretion and neutrophil infiltration. In each biopsy, 10 microscopic fields were analysed, using a magnification of 312.5 (objective X25).
Dating of the endometrial samples was done in relation to the day of LH surge in normal cycles (HCG = LH-2/-1). The samples from the luteal phase were further divided into early secretory (LH+2 to LH+6) and mid-late secretory phase (LH+7 and beyond). The endometrial dating was defined as histological dating in days minus chronological dating from the LH surge. In the control group the mean daring was set at 0 days.
The IMTEC/EXCELL system was used for the analysis of the size and shapes of images derived from an Olympus BH microscope via a videocamera. Using quantitative assessment of the grey scale (EDIS program, IMTEC AR), the volume densities of the endometrial glands, glandular epithelium and stroma were calculated.
Statistical analysis
Values are given as means ± SD. The data were calculated using the two-sided non-parametric Mann-Whitney [/-test For mean comparisons, analysis of variance (ANOVA) was performed wherever appropriate. A corrected P value (Bonferroni P value) was used to account for multiple comparisons. A regression analysis was performed to examine possible correlations between hormone and morphometric parameters. All calculations were performed using GraphPAD/InStat software. Level of significance was P < 0.05.
Results
Data on serum oestradiol and progesterone concentrations on the day of endometrial biopsy, the dose of clomiphene citrate used, and their endometrial dating are summarized in Table I for all 21 women in the clomiphene citrate treatment group. As shown in Table II , there seemed to be a dose-response effect between the clomiphene citrate and the steroid concentrations during the late luteal phase. The plasma steroids were higher among the women who had received 5=100 mg clomiphene citrate per day than among the women treated with 50 mg clomiphene citrate per day. However, there were no statistically significant differences between the treatment groups. This lack of significance could probably be explained by the small numbers of women investigated in the late luteal phase. Endometrial dating in the clomiphene citrate group was 0.88 (range -2.5 to +8.5) in the early luteal phase (LH+2/+6; n = 8); in the later secretory phase (LH>+7) the mean was -0.42 (range -2.5 to +3.0; n = 6). When clomiphene citrate was given at a dose of > 100 mg/day (a total of 11 cases) six biopsies could not be dated, whereas in the remaining five cases dating ranged from -2.5 to +8.5.
Endometrial assessment
The histological evaluation took into account the degree of glandular development, stromal appearance and the synchrony between glandular and stromal responses. The results of the semiquantitative morphometric analysis of clomiphene citratetreated women were compared with data obtained from biopsies of fertile women matched for age and equivalent days of the cycle (Table ITI) . The hormone profile of the fertile group was in accordance with normal luteal function (Johannisson et al., 1987) .
The semiquantitative morphometric evaluation indicated that, after clomiphene citrate treatment in the early secretory phase (LH+2/+6), the number of glands and the height of the glandular epithelial cells were reduced when compared to the data from fertile women {P < 0.05). The glandular diameter in both groups did not differ significantly; however, glandular size increased less in the mid to late luteal phase (=» LH+7) after clomiphene citrate treatment when compared to the controls. The percentage of epithelial cells with basal vacuoles, peaked 4-5 days after ovulation in fertile cycles and remained elevated in the mid to late luteal phase after clomiphene citrate treatment This indicated an impairment of the secretory transformation, although a large variation between patients was observed (Figure 1) .
The parameters assessed by the scoring system did not show significant differences between fertile and clomiphene citratetreated women. However, in clomiphene citrate-treated biopsies a tendency to early predecidualization and increased oedema was observed in the early luteal phase, but was reduced in the mid to late luteal phase when compared to fertile women (data not shown). When using morphometric parameters for biopsy evaluation, mainly morphological changes of the glandular compartment were recorded and the development of the stromal cells was assessed only by a more subjective scoring system. To improve the evaluation system, a stereological analysis of selected biopsies was performed using an image analysing system (IMTEC/EXCELL system; for details, see Bonhoff et al, 1993) . Volume densities of the glandular lumen, the glandular epithelial cells and the stroma were determined in 12 biopsies after clomiphene citrate treatment, and the data are summarized in Table IV . When biopsies of fertile and clomiphene citratetreated women were compared, significant differences were seen between the endometrium of the treated women and the controls in glandular epithelial cell density (P < 0.05) and amount of stroma (P < 0.05) in the early luteal phase, as well as decreased glandular size (P < 0.05) and increasing amount of stroma (P < 0.05) during the mid to late luteal phase. These differences point to a disturbed transformation of the secretory endometrium in the treated group. The parameters 'glandular diameter' and 'epithelial height' are equivalent to the parameters 'density of endometrial gland' and 'volume density of glandular epithelium'. Therefore, the results obtained by stereological analysis and by semiquantitative morphometry were similar. However, it should be emphasized that stereological analysis cannot be fully replaced by semiquantitative morphometry.
Discussion
The treatment of infertility using various pharmacological agents for ovarian stimulation has become a routine procedure in gynaecology. However, despite improved follicular responses (growth of follicles, ovulation rates and steroid concentrations), pregnancy rates are still unsatisfactory. Clomiphene citrate has been the most popular agent for ovarian stimulation due to its ease of application and relative safety, as well as low costs for the treatment cycle. The adverse effects, such as hot flushes and visual disturbances, are usually benign (Blankstein, 1991) . However, it has been reported that clomiphene citrate and other fertility-stimulating drugs could be associated with epithelial ovarian cancer (Rossing et al., 1994) . Nevertheless, this potential relationship is controversial and causality has yet to be proven (Balasch and Barri, 1993) . The accumulation of clomiphene citrate within certain target tissues and adverse effects on the uterine environment have been described previously (Fazlebas et al, 1991; Yeko et aL, 1992; Rodin et al, 1994) . Whether or not clomiphene citrate exerts a negative influence on endometrial development when used alone or in combination with human menopausal gonadotrophin (HMG) is still an open question (Sterzik et al, 1988; Bonhoff et al, 1990; Gonen and Casper, 1990; Rogers etal, 1991) .
Preliminary observations in a small group of clomiphene citrate-treated patients had led to speculations of a dose-related effect of the compound on endometrial structure and steroid concentrations (Bonhoff etal, 1993) . Consequently, in the present study, retrospective endometrial biopsies of 21 patients with unexplained infertility were evaluated after ovarian stimulation for artificial insemination. We used a widely accepted dosage and treatment regimen for administration of the clomiphene citrate, and endometrial biopsies were timed to coincide with the implantation period.
As the endometrium undergoes a series of developmental changes in response to the alterations of the steroid concentrations, the tissue can be dated precisely in normal fertile women (Johannisson et al, 1987) . In our study, the postovulatory phase was divided into early luteal phase (LH+2/+6) and mid to late luteal phase (LH+7 and beyond), which is characterized by extensive secretory activity of the glands and the reorganization of the stroma to form a predecidua with the capacity to secrete peptides such as relaxin and prolactin as well as many other factors (Bryant-Greenwood et al, 1993) . During this time, when a receptive uterine environment is believed to be achieved by synchronously differentiated endometrial components, we observed in seven out of 21 (33%) biopsies analysed that tissue had developed asynchronously after clomiphene citrate treatment. This was classified as irregular secretory activity, and all but one of the patients exhibiting this condition had received doses of clomiphene citrate >100 mg/day. In addition, one patient (no. 2) showed a vastly premature endometrial development after treatment with 100 mg of clomiphene citrate/day (chronological date LH+3, dated LH +11/+12; endometrial dating + 8.5). No significant dose-dependent increase in steroid concentrations was observed in the higher dose group, probably due to individual variability. Similar variability in secretion rates was observed by Quigley et al (1984) in patients treated with 50 or 150 mg clomiphene citrate daily, even though in these patients oestradiol concentrations in the 150 mg dosage group were higher during the entire luteal phase, with progesterone concentrations similar in both treatment groups. Quigley et al (1984) reported that pregnancies occurred exclusively after treatment with 50 mg clomiphene citrate.
In our study, 50 mg of clomiphene citrate per day induced moderate increases of oestradiol and progesterone and resulted in secretory transformation of the endometrium that was similar to that of fertile controls during the early luteal phase (endometrial dating +0.88). A higher clomiphene citrate dosage (2*100 mg/day) usually resulted in greatly diverging morphological alterations. Originally, endometrial receptivity was thought to be hampered by abnormal oestradiol/pTOgesterone ratios. This concept is now being challenged, as even maximal alterations of oestradiol/progesterone fail to affect endometrial morphology (de Ziegler and Bouchard, 1993) .
In many stimulation protocols, clomiphene citrate dosages higher than those used in the present study were administered. It cannot be excluded that such high doses intensified the abnormal development of the endometrium due to factors other than steroids in infertile patients. In spontaneous cycles of infertile women, impaired glandular maturation has also been reported after morphometric evaluation (Bonhoff et al., 1990; Li et al, 1991) . Dockery et al. (1990) found an increasing packing density of stroma between LH+2 and LH+6 in infertile women, which decreased substantially at later stages (LH+8 to LH+10). This corresponds to the time when the stromal oedema reaches its maximum and when the development of predecidualization also starts. This finding is in contrast to the observation of early oedema and predecidualization in the early luteal phase of clomiphene citrate-treated patients which results in desynchronized endometrial dating.
Stromal oedema and predecidualization are likely to be associated with progesterone production in the luteal phase. However, no correlation was found between progesterone concentrations and the predecidua scores in clomiphene citratetreated patients in the present study. Alterations in the stromal cells during the luteal phase leading to decidualization may be essential for a successful implantation, and significant changes in the stromal morphology might be deleterious for the nidation process. Serle et aL (1994) demonstrated that, in cases of recurrent miscarriages, morphological retardation of the endometrium in combination with abnormal epithelial function might be responsible for the negative pregnancy outcome.
In conclusion, the results of this study show small but measurable differences in endometrial development between fertile and clomiphene citrate-treated patients. The frequency of abnormalities was found to be similar whether using clomiphene citrate or a combination of clomiphene citrate/ HMG in infertile patients, as shown in a previous study (Bonhoff et aL, 1993) . Unfortunately, no pre-treatment biopsies could be performed in the patient group and no definite conclusions can be drawn from the results of the present study. Therefore, the factor causing the observed differences in endometrial morphology in infertile patients treated with clomiphene citrate remains to be determined. Such studies are at present underway.
